BRK-B vs QFIN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
QFIN presents a classic deep-value opportunity, characterized by a stable Piotroski F-Score of 4/9 and a massive valuation disconnect, trading at $14.13 against a Graham Number of $64.94. While the company is facing severe earnings contraction (-40.9% YoY) and a completely bearish technical trend (0/100), its fundamental profitability remains robust with an ROE of 24.69% and a very low P/E of 2.19. The high dividend yield of 10.89% is well-supported by a low payout ratio of 23.85%, providing a significant safety buffer. The bullish assessment is based on the extreme margin of safety provided by the Price-to-Book ratio of 0.49.
Compare Another Pair
Related Comparisons
BRK-B vs QFIN: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Qfin Holdings, Inc. (QFIN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.